BRAIN Biotech Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.

Ownership Breakdown

What is the ownership structure of BNN?
Owner Type	Number of Shares	Ownership Percentage
Institutions	3,452,046	15.8%
General Public	7,231,379	33.1%
Private Companies	11,164,070	51.1%

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.

Top Shareholders

Top 18 shareholders own 66.9% of the company

Ownership	Name	Shares	Current Value	Change %	Portfolio %
45.5%	MP Beteiligungs-GmbH	9,940,610	€21.9m	0%	no data
5.6%	Service Innovation Group GmbH	1,223,460	€2.7m	0%	no data
4.99%	Universal Investment GmbH	1,089,743	€2.4m	0%	no data
2.1%	LLB Swiss Investment AG	458,260	€1.0m	0%	0.17%
1.65%	Deka Investment GmbH	359,470	€790.8k	0%	no data
1.58%	Joh. Berenberg, Gossler & Co. KG	345,197	€759.4k	0%	0.04%
1.51%	Meag Munich Ergo AssetManagement GmbH	329,385	€724.6k	0%	0.13%
1.17%	FPM Frankfurt Performance Management AG	256,000	€563.2k	9.87%	0.69%
1.02%	Deutsche Asset & Wealth Management	222,000	€488.4k	0%	no data
0.64%	Lampe Asset Management GmbH	140,000	€308.0k	0%	0.03%
0.33%	Generali Investments, druzba za upravljanje, d.o.o.	71,373	€157.0k	0%	0.02%
0.27%	Sparkasse Mittelthüringen	60,000	€132.0k	0%	0.09%
0.27%	KBC Asset Management NV	58,105	€127.8k	0%	no data
0.092%	WSS Vermögensmanagement GmbH	20,000	€44.0k	0%	0.05%
0.077%	Sp-Rahastoyhtiö Oy	16,800	€37.0k	0%	no data
0.055%	Kirix VermÖGensverwaltung AG	12,000	€26.4k	0%	0.06%
0.046%	SMS & Cie Vermoegensmanagement GmbH	10,000	€22.0k	0%	0.24%
0.017%	Franklin Resources, Inc.	3,713	€8.2k	-35%	no data

Company Analysis and Financial Data Status

Data	Last Updated (UTC time)
Company Analysis	2025/10/06 10:24
End of Day Share Price	2025/10/03 00:00
Earnings	2025/06/30
Annual Earnings	2024/09/30

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

Package	Data	Timeframe	Example US Source ^*
Company Financials	10 years	Income statement Cash flow statement Balance sheet	SEC Form 10-K SEC Form 10-Q
Analyst Consensus Estimates	+3 years	Forecast financials Analyst price targets	Analyst Research Reports Blue Matrix
Market Prices	30 years	Stock prices Dividends, Splits and Actions	ICE Market Data SEC Form S-1
Ownership	10 years	Top shareholders Insider trading	SEC Form 4 SEC Form 13D
Management	10 years	Leadership team Board of directors	SEC Form 10-K SEC Form DEF 14A
Key Developments	10 years	Company announcements	SEC Form 8-K

^* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

BRAIN Biotech AG is covered by 13 analysts. 4 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

Analyst	Institution
Gerhard Schwarz	Baader Helvea Equity Research
Volker Bosse	Baader Helvea Equity Research
Thomas Meyer	Baader Helvea Equity Research